Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturerAgreement will secure a reliable ...

Sandoz garners chunky demand for 10 year trade ◆ Trend continues for issuers to set deal parameters quickly ◆ Single digit ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first ...

Global drugmaker Novartis is laying off 427 employees at East Hanover later this spring and summer, after it let go of 235 employees at the Morris County site last year, filings with the New Jersey ...

Swiss generics and biosimilars giant Sandoz today announced financial results for the full year 2024, showing that sales were ...

Sandoz last year agreed to pay $265 million to resolve related claims lodged in the litigation by a group of wholesale drug purchasers and others. The case is In re Generic Pharmaceuticals Pricing ...

Sandoz was one of the two predecessor companies of Novartis. The pharmaceutical giant emerged in 1996 from the merger of the company with the pharmaceutical and chemical group Ciba-Geigy.

Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...

Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 billion). The Sandoz Family Foundation, through the vehicle Emasan AG ...

For Europe, it is still too early to model,” Sandoz CEO Richard Saynor said in a statement to Pharmaceutical Technology. Sandoz pointed to the uptake of its Humira biosimilar Hyrimoz in the US ...